Scholarlink

Purpose <p>This study evaluates quercetin’s ability to prevent liver and spleen disorders caused by gamma radiation in an experimental rat model and investigates the potential mechanism.</p> Methods <p>Four sets of eight rats were randomly selected. Group I served as a negative control, and Group II received a single dose of γ-radiation (7&#xa0;Gy). Group III was given 200&#xa0;mg/kg of quercetin daily for ten days. Group IV: Rats were pretreated with quercetin for ten days; on the seventh day of quercetin treatment, the animals were subjected to a single dose of γ-radiation (7&#xa0;Gy). AST, ALT, albumin and total protein levels are measured in serum as well as oxidative biomarkers contents (ROS and GSH) are estimated in liver and spleen tissues.IL-6 and TGF-β protein expression are quantified immunohistochemically in addition to histopathological examination of liver and spleen tissues of rats.</p> Results <p>The liver and spleen tissues of irradiated rats have lower amounts of GSH and higher levels of reactive oxygen species (ROS) as compared to the control. Additionally, there was an increase in serum alanine transaminase (ALT) and aspartate aminotransferase (AST) and upregulation of transforming growth factor beta (TGF-β) and interleukin-6 (IL-6) expression, while serum albumin and total protein concentrations decreased. Conversely, oral quercetin pretreatment significantly improved indicators of liver function. Histopathological architecture and immunohistochemical analysis of fibrogenic and inflammatory biomarkers (IL-6 and TGF-β) validated the bioactivity of the flavonoid. By controlling IL-6 and TGF-β expression, quercetin reduced radiotherapy-induced liver damage, possibly via mitigating liver oxidative stress, inflammation, and fibrosis.</p> Conclusion <p>To reduce the hepatic and splenic toxicity caused by radiation therapy, quercetin may be administered as a safe, stand-alone radioprotective medication.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Hepatosplenic protective role of quercetin in gamma-irradiated rats: modulation of oxidative stress, inflammatory and TGF-β signaling pathways

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月1日

查看全文
  • Fatma Y. Abdou,
  • Ola A. Gharib,
  • Hanan A. Fahmy

摘要

Purpose

This study evaluates quercetin’s ability to prevent liver and spleen disorders caused by gamma radiation in an experimental rat model and investigates the potential mechanism.

Methods

Four sets of eight rats were randomly selected. Group I served as a negative control, and Group II received a single dose of γ-radiation (7 Gy). Group III was given 200 mg/kg of quercetin daily for ten days. Group IV: Rats were pretreated with quercetin for ten days; on the seventh day of quercetin treatment, the animals were subjected to a single dose of γ-radiation (7 Gy). AST, ALT, albumin and total protein levels are measured in serum as well as oxidative biomarkers contents (ROS and GSH) are estimated in liver and spleen tissues.IL-6 and TGF-β protein expression are quantified immunohistochemically in addition to histopathological examination of liver and spleen tissues of rats.

Results

The liver and spleen tissues of irradiated rats have lower amounts of GSH and higher levels of reactive oxygen species (ROS) as compared to the control. Additionally, there was an increase in serum alanine transaminase (ALT) and aspartate aminotransferase (AST) and upregulation of transforming growth factor beta (TGF-β) and interleukin-6 (IL-6) expression, while serum albumin and total protein concentrations decreased. Conversely, oral quercetin pretreatment significantly improved indicators of liver function. Histopathological architecture and immunohistochemical analysis of fibrogenic and inflammatory biomarkers (IL-6 and TGF-β) validated the bioactivity of the flavonoid. By controlling IL-6 and TGF-β expression, quercetin reduced radiotherapy-induced liver damage, possibly via mitigating liver oxidative stress, inflammation, and fibrosis.

Conclusion

To reduce the hepatic and splenic toxicity caused by radiation therapy, quercetin may be administered as a safe, stand-alone radioprotective medication.

Graphical Abstract